Both of Tesla's previous stock splits happened during the month of August -- but don't expect another one to happen two ...

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

Stock splits are no longer as routine as they were a couple of decades ago, but a string of high-profile ones has put the subject back in the spotlight. In 2025, Netflix (NASDAQ:NFLX) executed a ...

Stock splits stir up a lot of noise in the world of investing. A stock split doesn’t change the value of a company but can influence investor sentiment and market activity. That said, a stock split ...

J.B. Maverick is an active trader, commodity futures broker, and stock market analyst 17+ years of experience, in addition to 10+ years of experience as a finance writer and book editor. David ...

Yesterday, Banzai International, Inc. (NASDAQ:BNZI) announced a 1‑for‑10 reverse stock split, set to take effect July 8, 2025. Here’s a comprehensive guide explaining what that means—and how similar ...

Splits aren't an explicit buy signal. PEGA and IBKR are two recent examples of splits. Splits help knock down barriers of entry. We’ve seen many notable splits in recent years, with companies aiming ...

The operation should make it easier for a broader range of investors to buy the stock.

These companies decided on stock splits after periods of fantastic stock performance. A stock split lowers the per-share price but doesn’t change anything fundamental about the company. These 10 ...

Stock splits usually give you many more shares. But the total value of your stake in the company won't change much. There are more important considerations than stock splits, when you're stock-hunting ...

One of the biggest winners of the artificial intelligence (AI) boom has been chipmaker Nvidia (NASDAQ: NVDA). The company's revenue has soared more than 1,000% over the last five years, and its share ...

NEW YORK--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...